A “Revolution”: Oncothyreon CEO on Alpine Biosciences Acquisition

By August 17, 2014 Portfolio Company News

Seattle-based oncology company Oncothyreon Inc. has acquired Alpine Biosciences, a Seattle-based biotechnology company developing what are called “protocells” — basically nanotechnology that uses biological materials to deliver precisely targeted treatments to patients.

Read the Full Article

Leave a Reply